The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease-Reference-Cited by-同舟云学术

The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease

Published:2022-05-23 Issue:7 Volume:13 Page:e00504
ISSN:2155-384X
Container-title:Clinical and Translational Gastroenterology
language:en
Short-container-title:Clinical and Translational Gastroenterology

Author:

Wu Tingfeng,Ye Junzhao,Shao Congxiang,Lin Yansong,Wang Wei,Feng Shiting,Zhong Bihui

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference39 articles.

1. Disease progression of non-alcoholic fatty liver disease: A prospective study with paired liver biopsies at 3 years;Wong;Gut,2010

2. Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative;Chan;Aliment Pharmacol Ther,2018

3. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

4. Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease;Haflidadottir;BMC Gastroenterol,2014

5. NAFLD and increased risk of cardiovascular disease: Clinical associations, pathophysiological mechanisms and pharmacological implications;Targher;Gut,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge;Metabolism and Target Organ Damage;2024-06-26

2. Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review;Indian Journal of Gastroenterology;2023-12-01

3. Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia;Journal of Clinical Lipidology;2023-11

4. Systematic review and meta‐analysis: Association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease;Alimentary Pharmacology & Therapeutics;2023-06-22

5. Associations between apolipoprotein B/A1 ratio, lipoprotein(a), and the risk of metabolic-associated fatty liver diseases in a Korean population;Laboratory Medicine;2023-04-13